24/7
Buzz
Startups
VC
@work
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
DataTech
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
License
Tags search
HOME
24/7
buzz
STARTUPS
VC
Tech@work
Innovation
OPINIONS
EVENTS
ABOUT
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
12:03
How did an Israeli startup's valuation plummet from $5 billion to $50 million?
11:49
CTech's Book Review: Understanding how habits can change our lives
09:48
From startup nation to watertech nation
19:43
Unicorn Gong cuts 80 jobs, 7% of workforce
More stories
Buzz
Most popular
Daily
Weekly
1
Unicorn Gong cuts 80 jobs, 7% of workforce
2
“Intel faces difficult strategic choices and needs to figure out what the company will look like in the future”
3
Quiet Hiring: The new trend in talent management
4
Fintech startup Wisor AI raises $8 million in Seed for freight booking software solution
5
Cybersecurity company Cyren on verge of shut down after laying off entire workforce
More news
License
5 stories about License
Insurtech company WeSure expanding to U.S., receives New Jersey license
07.06.21
|
Almog Azar
The Israeli company will be able to sell products to both individuals and businesses in NJ and intends to apply for additional licenses in other states
Defense Ministry Suspends Export License of Interception Company Ability Subsidiaries
27.03.19
|
Adi Pick
The defense ministry suspended the export and marketing licenses of the two companies due to “violations of the defense export control law”
Aeronautics Wins Contract With Client Linked to Previous Probe
17.02.19
|
Hezi Sternlicht
Earlier this month, the Israeli defense ministry reinstituted effective immediately Aeronautics' export license
Israel Reinstitutes Export License of Probed Drone Maker Aeronautics
04.02.19
|
Lilach Baumer
In 2017, the Ministry of Defense halted Aeronautics' license to export a loiter munition UAV system to an unnamed client
AstraZeneca Signs Deal with Cancer Immunotherapy Company Compugen
03.04.18
|
Lilach Baumer
The deal has the potential to be worth over $200 million for Nasdaq-listed Compugen